TEODULO PEREZ: Open Payments
NPI 1043817232 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 62 payments from 14 companies in 2025. Trend: 2023 $1,496 · 2024 $1,729 · 2025 $1,489
Food & beverage: $1,455Education: $34
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $328 |
| AstraZeneca Pharmaceuticals LP | 11 | $266 |
| GENZYME CORPORATION | 7 | $239 |
| GlaxoSmithKline, LLC. | 11 | $158 |
| Amgen Inc. | 4 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Pharming Healthcare, Inc. | 2 | $51 |
| BioCryst US Sales Co., LLC | 2 | $49 |
| Optinose US, Inc. | 2 | $49 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, AIRSUPRA, NEFFY, RUCONEST, FASENRA, ORLADEYO.
Industry payments across FL — which companies pay providers there.
